FDA Approves Moderna’s mRNA Flu Vaccine for Adults 50 and Older
The U.S. Food and Drug Administration approved Moderna’s mRNA influenza vaccine, mFLUSIVA, for adults aged 50 and older, marking the first time the agency has licensed an mRNA vaccine for seasonal influenza, according to a company statement reported by The Epoch Times [1]. Moderna said the FDA granted traditional approval for adults aged 50 to 64 and accelerated approval for adults 65 and older.
Read Full Article: https://www.naturalnews.com/2026-08-07-fda-approves-moderna-mrna-flu-vaccine-elderly.html
